• Tianjin Pharmaceutical Da Ren Tang held its sixth FY2026 board meeting on Aug. 7 via in-person session, teleconference.
• Board cleared an annual distribution agreement via its Health Technology Industry Development Branch with Tianjin Pharmaceutical Group Taiping Medicine, Tianjin Zhongxin Medicine.
• Board also endorsed a warehousing and logistics cooperation agreement with Tianjin Pharmaceutical Group Taiping Medicine.
• Interested directors Guo Min, Wang Lei, Xing Jianhua, Mao Weiwen abstained from voting on both related-party transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tianjin Pharmaceutical Da Ren Tang Group Corporation Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: VDEB1TKLZQDRULJ1) on August 07, 2026, and is solely responsible for the information contained therein.